July 2024: New NIH grant alert – Selective inhibitors of MLCL/CytC Peroxidase in Barth Syndrome
The Greenberg lab was awarded a multi-investigator NIH R01 grant (with Dr. Valerian Kagan, University of Pittsburgh, and Dr. Hülya Bayir, Columbia University). The grant, entitled “Selective inhibitors of MLCL/CytC Peroxidase in Barth Syndrome,” aims to identify selective inhibitors of a newly identified pathogenic mechanism of Barth syndrome. More about the grant here:
